My Approach
A driven structured, strategic and organized thinker and demonstrated leader with 20+ years of experience in the biopharmaceutical industry helping to drive innovation and deliver new products/drugs in the ever-evolving healthcare business.
Serves as a catalyst to drive change based on facts and qualified research, as well as to leverage a strong background across disease areas, namely in oncology and autoimmunity, with expertise in pharmacology, biomarker / translational research and end-to-end drug development of both small molecules and biologics.
In-depth analytical skills together with a strong cross stakeholders matrix / interfaces engagement to identify and address gaps / deficiencies and their interdependencies. To then generate solutions to drive business value and stay ahead of the curve in a very dynamic environment shaped by rapidly evolving expectations of value-based packages combined with innovative disruptive tools that constantly challenge the healthcare systems (real-world patient data, regulatory and payers expectations, technologies, etc.) that need to be incorporated into the drug development planning to optimize chances of approval and positioning on the market upon approval.
I apply a non-hierarchical mindset in a constructive manner where each partner feels him- or herself as an “owner”. I'm open to questions in a continuous learning manner to support and contribute to the creation and maintenance of the dynamic and global “vision” during a project performance while being conscious about maintaining agility and timelines. Being open to challenges and proactively define back-up strategies.
I have worked throughout my various jobs in cooperation with a broad spectrum of line-functions and specialties (research, CMC, devices, bioanalytics, toxicology, clinical, regulatory affairs, medical affairs, business development, portfolio management and commercial). Contributing author on several successful IND, CTD, BLA regulatory filings.
I have been exposed to both small to medium-sized biotech and large pharma (i.e., understanding of the two mindsets) as well as a broad spectrum of external partners.
I am skilled at providing support in the implementation of novel tools, technologies, diagnostics expertise and strategy to pharma leadership teams in multiple disease areas.
Experience in a broad spectrum of roles in the United States, Germany, and Switzerland.
Additional information in the form of CV and references available upon request.